Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$185.08B | 62.7x | 0.11 | NT$556 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.8% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$33.27B | -77.9x | 1.02 | NT$197 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$32.94B | -14.5x | 0.19 | NT$44.15 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$25.26B | -181.2x | -8.78 | NT$92.50 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$17.92B | 25.5x | 1.25 | NT$329 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$16.79B | -6.5x | -0.3 | NT$70.50 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.38B | -6.1x | 0.05 | NT$58.50 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.09B | 8.6x | 0.02 | NT$105 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.9% Upside | Upgrade to Pro+ | |
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.10B | -117.7x | -3.11 | NT$103.50 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.92B | -12.4x | -1.91 | NT$83.50 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.53B | -18.1x | -0.57 | NT$41.30 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.87B | -11.8x | -0.38 | NT$34.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.98B | 71.9x | -2.16 | NT$78.50 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Senhwa Biosciences | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.78B | -13.2x | -4.99 | NT$42.40 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SINEW Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.61B | -24.5x | -1.81 | NT$50.60 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiRx | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.20B | -15.6x | -0.71 | NT$28.95 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GlycoNex | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.60B | -11.4x | 0.47 | NT$24.05 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Golden BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.49B | -5.8x | 0.08 | NT$15.35 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied BioCode | Taiwan | Healthcare | Biotechnology & Medical Research | NT$2.31B | -9.7x | NT$22.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.2% Downside | Upgrade to Pro+ | ||
Genesis Genetics Asia | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.81B | 31.6x | 0.28 | NT$68 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abnova | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.80B | 29.1x | 0.71 | NT$29.75 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiwan Advance Bio-Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.45B | 67.4x | 0.44 | NT$16.10 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kim Forest Enterprise | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.36B | -7.5x | 0.2 | NT$22.35 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dv Biomed | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.31B | 20.8x | -0.33 | NT$63.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomics BioSci &Tech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.31B | -8.2x | 0.09 | NT$18.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynCore BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.21B | 3,450x | 33.17 | NT$34.55 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Twi BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.05B | -4.4x | 0.03 | NT$12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inalways | TPEX | Healthcare | Biotechnology & Medical Research | NT$952.21M | -1,130x | -11.28 | NT$19.25 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLASCO Taiwan | TPEX | Healthcare | Biotechnology & Medical Research | NT$865.69M | 20.4x | -4.08 | NT$33.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofiva Genomics | TPEX | Healthcare | Biotechnology & Medical Research | NT$863.74M | 41.5x | -1.02 | NT$40 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiwanJ Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$742.73M | -24.7x | -0.43 | NT$9.27 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Welgene Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$541.82M | 460x | 3.4 | NT$23.25 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |